EPIC Retirement Plan Services
Randall & Hurley, Inc.
Loren D. Stark Company
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|What's Next for Drug Pricing in the U.S.?|
White & Case LLP, via Lexology; free registration required
June 9, 2021
"Three [proposed] bills would change US antitrust laws to target 'reverse payment' patent settlements, 'product hopping' and 'sham' citizen petitioning. A fourth bill would cap the number of patents in an infringement action resulting from a 'patent dance' information exchange in the abbreviated approval pathway for biosimilars. Supporters claim these bills would target conduct that supposedly prevents or slows competition from less-expensive drugs."
|Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).|
|An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).|